Category BUSINESS

UK-based AstraZeneca intends to put $15B into China by 2030.

The firm, based in Cambridge, UK, stated the investment will aid in “developing cutting-edge pharmaceuticals.” “Today’s significant investment of $15 billion initiates an exciting new period for AstraZeneca in China, which has evolved into a pivotal force in scientific advancement,…